Zobrazeno 1 - 10
of 413
pro vyhledávání: ''
Autor:
Huay-Min Wang, Sung-Shuo Kao, Wen-Chi Chen, Yun-Da Li, Jin-Shiung Cheng, Chun-Hao Yin, Yuan-Rong Li, Feng-Woei Tsay, Tzung-Jiun Tsai, Wei-Lun Tsai, Wei-Chih Sun, Huey-Shyan Lin, Chia-Ming Lu
Publikováno v:
Antimicrob Agents Chemother
Spontaneous severe acute exacerbation (SAE) is not uncommon in the natural history of chronic hepatitis B (CHB). Lamivudine (LAM) has the advantages of low price, quick onset, good efficacy, and no drug resistance within 24 weeks. This study aimed to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80bead1c7cb3ca30f7f286b4ba7a304d
https://europepmc.org/articles/PMC8846303/
https://europepmc.org/articles/PMC8846303/
Autor:
Nicholas K. Goldner, Thomas J. Walsh, Ethan Naing, Christina A. Sutherland, Aki Yoneda Kau, Vidmantas Petraitis, Andrew Garcia, Ruta Petraitiene, David P. Nicolau, Christopher Bulow, Povilas Kavaliauskas
Publikováno v:
Antimicrob Agents Chemother
Methicillin-resistant Staphylococcus aureus (MRSA) infections of surgically implanted subcutaneous vascular catheters (SISVCs) cause serious morbidity in patients with chronic illnesses. Previous in vitro and murine models demonstrated the synergisti
Autor:
Kileen L. Shier
Publikováno v:
Journal of Clinical Microbiology
SARS-CoV-2 is a novel positive-sense single-stranded RNA virus that has caused a recent pandemic. Most patients have a mild disease course, while approximately 20% have moderate to severe disease, often requiring hospitalization and, in some cases, c
Publikováno v:
Journal of Clinical Microbiology. 59
SARS-CoV-2 is a novel positive-sense single-stranded RNA virus that has caused a recent pandemic. Most patients have a mild disease course, while approximately 20% have moderate to severe disease, often requiring hospitalization and, in some cases, c
Autor:
Constant Edi, Yashpal S. Chhonker, Benjamin G. Koudou, Abdullah Alshehri, Christopher L. King, Daryl J. Murry, Catherine M. Bjerum, Veenu Bala
Publikováno v:
Antimicrob Agents Chemother
Diethylcarbamazine (DEC) is a drug of choice to treat lymphatic filariasis (LF) either used alone or in combination as mass drug administration (MDA) preventive strategies. The objective of this study was to develop a population pharmacokinetics (PK)
Autor:
Tamara Al Naimi, Ryan L. Crass, Bo Wen, Shijing Jia, Ernane Souza, Manjunath P. Pai, Susan Murray
Publikováno v:
Antimicrob Agents Chemother
Background: The optimal polymyxin B dosage needed to achieve an efficacy target of 50-100 mg·h/L when treating multi-drug-resistant bacterial infections in adult cystic fibrosis (CF) patients is unclear. The pharmacokinetics of intravenous polymyxin
Autor:
Kohta Saito, Carl Nathan, Saurabh Mishra, Oksana Ocheretina, Daniel W. Fitzgerald, Laurent Mathurin, Kathleen F. Walsh, Myung Hee Lee, Stalz Charles Vilbrun, Kayvan Zainabadi, Jean W. Pape
Publikováno v:
Antimicrobial Agents and Chemotherapy
Standard methods for enumerating Mycobacterium tuberculosis in patient sputum can miss large populations of viable M. tuberculosis cells that are unable to grow either on solid medium or in liquid medium unless the medium has been extensively diluted
Autor:
Pieter Guetens, Erin Sauve, Nguyen Van Hong, Anna Rosanas-Urgell, Ro Mah Huan, Nguyen Thi Hong Ngọc, Nguyen Thi Huong Binh, Nguyen Thị Thu Hien, Nguyen Duc Long, Johanna Helena Kattenberg, Annette Erhart, Eduard Rovira-Vallbona, Nguyen Luong Hieu, Nguyen Xuan Xa, Vu Thi Sang, Tran Thanh Duong
Publikováno v:
Antimicrobial Agents and Chemotherapy. 65
Chloroquine (CQ) is the first-line treatment for Plasmodium vivax malaria in most countries where malaria is endemic. Monitoring P. vivax CQ resistance (CQR) is critical but remains challenged by the difficulty to distinguish real treatment failure f
Autor:
Eleni Volakli, Emmanuel Roilides, Cornelia B. Landersdorfer, Roger L. Nation, Stavroula Ilia, Evangelos Gikas, Helen Gika, Anastasia Geladari, Charalampos Antachopoulos, Maria Sdougka
Publikováno v:
Antimicrob Agents Chemother
Limited pharmacokinetic (PK) data suggest that currently recommended pediatric dosages of colistimethate sodium (CMS) by the Food and Drug Administration and European Medicines Agency may lead to suboptimal exposure, resulting in plasma colistin conc
Autor:
Nicholas J. White, Nicholas P. J. Day, Melba Gomes, Richard M. Hoglund, Caterina I. Fanello, Charlie Kabedi, Marie A. Onyamboko, Phettree Niamyim, Daddy Kayembe, Sue J. Lee, Pauline Ndjowo, Charles J. Woodrow, Benjamin B. Badjanga, Joel Tarning
Publikováno v:
Antimicrobial Agents and Chemotherapy
When severe malaria is suspected in children, the WHO recommends pretreatment with a single rectal dose of artesunate before referral to an appropriate facility. This was an individually randomized, open-label, 2-arm, crossover clinical trial in 83 C
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6849a5a8c9ac4a404c81480ce7660b3
https://doi.org/10.1128/aac.02223-20
https://doi.org/10.1128/aac.02223-20